If confirmed, our current data with AMG 076 would suggest that antagonism of MCHR1 alone may exert a likely moderate anti-obesity effect in monkeys and potentially in humans and combination with therapies targeting other pathways may be needed. The gene discussed is MCHR1; the disease is obesity due to melanocortin 4 receptor deficiency.